Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

NBS1 I171V variant underlies individual differences in chromosomal radiosensitivity within human populations.

Tytuł:
NBS1 I171V variant underlies individual differences in chromosomal radiosensitivity within human populations.
Autorzy:
Tomioka K; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Miyamoto T; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.
Akutsu SN; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.
Yanagihara H; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.
Fujita K; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.
Royba E; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan.; Center for Radiological Research, Columbia University Irving Medical Center, New York, 10032, USA.
Tauchi H; Department of Biological Sciences, Faculty of Science, Ibaraki University, Mito, 310-8512, Japan.
Yamamoto T; Program of Mathematical and Life Sciences, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, 739-8526, Japan.
Koh I; Department of Obstetrics and Gynecology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Hirata E; Department of Obstetrics and Gynecology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Kudo Y; Department of Obstetrics and Gynecology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Kobayashi M; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Okada S; Department of Pediatrics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8551, Japan.
Matsuura S; Department of Genetics and Cell Biology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553, Japan. .
Źródło:
Scientific reports [Sci Rep] 2021 Oct 04; Vol. 11 (1), pp. 19661. Date of Electronic Publication: 2021 Oct 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Original Publication: London : Nature Publishing Group, copyright 2011-
MeSH Terms:
Alleles*
Amino Acid Substitution*
Mutation*
Biological Variation, Population/*genetics
Cell Cycle Proteins/*genetics
Chromosomal Instability/*radiation effects
Nuclear Proteins/*genetics
Radiation Tolerance/*genetics
Binding Sites ; Biomarkers, Tumor ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; DNA Copy Number Variations ; Female ; Gene Editing ; Gene Knock-In Techniques ; Genetic Predisposition to Disease ; Humans ; Nuclear Proteins/metabolism ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/radiotherapy ; Protein Binding ; Radiation, Ionizing
References:
EMBO J. 2020 Jun 17;39(12):e103499. (PMID: 32368833)
Anemia. 2012;2012:238731. (PMID: 22693659)
Cancer Sci. 2020 May;111(5):1443-1451. (PMID: 32232911)
Cell. 2017 Feb 9;168(4):644-656. (PMID: 28187286)
J Natl Compr Canc Netw. 2020 Apr;18(4):380-391. (PMID: 32259785)
Mutagenesis. 2013 Nov;28(6):683-97. (PMID: 24113799)
Breast Cancer Res Treat. 2008 Nov;112(1):75-9. (PMID: 18049891)
J Radiat Res. 2016 Aug;57 Suppl 1:i11-i17. (PMID: 27068998)
Aging Cell. 2020 Nov;19(11):e13251. (PMID: 33094908)
Hum Genet. 2004 Oct;115(5):372-6. (PMID: 15338273)
Nature. 2001 May 17;411(6835):366-74. (PMID: 11357144)
Nature. 2015 Jun 11;522(7555):179-84. (PMID: 26017310)
Anticancer Res. 2007 Jul-Aug;27(4C):3015-8. (PMID: 17695489)
Mol Cancer. 2019 Nov 26;18(1):169. (PMID: 31767017)
Mol Cell. 2011 Sep 2;43(5):788-97. (PMID: 21884979)
Mol Biol Cell. 2008 Apr;19(4):1693-705. (PMID: 18256278)
Mol Cell. 2012 Aug 24;47(4):497-510. (PMID: 22920291)
Breast Cancer Res Treat. 2015 Jul;152(1):129-136. (PMID: 26022348)
Curr Oncol. 2018 Apr;25(2):e176-e180. (PMID: 29719442)
Cancer Res. 2014 Jul 15;74(14):3707-15. (PMID: 24830725)
EMBO J. 2006 Nov 29;25(23):5527-38. (PMID: 17082765)
Sci Rep. 2017 Jul 20;7(1):5996. (PMID: 28729543)
Nature. 2019 Dec;576(7785):149-157. (PMID: 31634902)
Nature. 2002 Nov 7;420(6911):93-8. (PMID: 12422221)
Hum Mol Genet. 2017 Nov 15;26(22):4429-4440. (PMID: 28973348)
Stem Cell Res Ther. 2017 Sep 29;8(1):197. (PMID: 28962667)
Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. (PMID: 27181684)
Science. 2020 Jul 31;369(6503):566-571. (PMID: 32732424)
Br J Cancer. 1998 Feb;77(4):614-20. (PMID: 9484819)
Mutat Res Rev Mutat Res. 2020 Oct - Dec;786:108342. (PMID: 33339572)
Radiat Res. 1990 Sep;123(3):345-7. (PMID: 2217731)
Nature. 2012 Jan 18;482(7383):53-8. (PMID: 22258507)
Nature. 2014 Apr 24;508(7497):469-76. (PMID: 24759409)
Genes Genet Syst. 2016;90(4):195-208. (PMID: 26616756)
Ann Agric Environ Med. 2019 Mar 22;26(1):1-7. (PMID: 30922021)
Asian Pac J Cancer Prev. 2012;13(11):5375-9. (PMID: 23317186)
Radiat Prot Dosimetry. 2007;124(2):115-23. (PMID: 18073230)
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714. (PMID: 31263220)
Cancer Res Treat. 2019 Jul;51(3):1180-1187. (PMID: 30590007)
Substance Nomenclature:
0 (Biomarkers, Tumor)
0 (Cell Cycle Proteins)
0 (NBN protein, human)
0 (Nuclear Proteins)
Entry Date(s):
Date Created: 20211005 Date Completed: 20211227 Latest Revision: 20211227
Update Code:
20240105
PubMed Central ID:
PMC8490386
DOI:
10.1038/s41598-021-98673-7
PMID:
34608183
Czasopismo naukowe
Genetic information is protected against a variety of genotoxins including ionizing radiation (IR) through the DNA double-strand break (DSB) repair machinery. Genome-wide association studies and clinical sequencing of cancer patients have suggested that a number of variants in the DNA DSB repair genes might underlie individual differences in chromosomal radiosensitivity within human populations. However, the number of established variants that directly affect radiosensitivity is still limited. In this study, we performed whole-exome sequencing of 29 Japanese ovarian cancer patients and detected the NBS1 I171V variant, which is estimated to exist at a rate of approximately 0.15% in healthy human populations, in one patient. To clarify whether this variant indeed contributes to chromosomal radiosensitivity, we generated NBS1 I171V variant homozygous knock-in HCT116 cells and mice using the CRISPR/Cas9 system. Radiation-induced micronucleus formation and chromosomal aberration frequency were significantly increased in both HCT116 cells and mouse embryonic fibroblasts (MEFs) with knock-in of the NBS1 I171V variant compared with the levels in wild-type cells. These results suggested that the NBS1 I171V variant might be a genetic factor underlying individual differences in chromosomal radiosensitivity.
(© 2021. The Author(s).)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies